Search results
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 1 day agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...
Philippe Laffont's Strategic Moves in Q1 2024: A Deep Dive into
Guru Focus· 6 days agoInsights into Coatue Management's Latest 13F Filing Philippe Laffont (Trades, Portfolio), the founder of Coatue Management, has made notable adjustments to his
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 6 days agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NVAX -4.30%) stock has...
Evercore ISI says three years of biotech underperformance may be ending, gives its 5 favorite stocks
CNBC· 7 days agoThe outlook on biotechnology is finally turning positive, according to Evercore ISI, which launched...
Jim Cramer’s Latest Stock Picks in May 2024
Insider Monkey via Yahoo Finance· 3 days agoJim Cramer on Friday analyzed the market rally following the latest CPI data which showed inflation was easing in April. Cramer said bears are clearly...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 7 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 7 days agoThese include innovative immuno-oncology combinations, including Keytruda with TIGIT, LAG3 and...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 5 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Philippe Laffont's Strategic Moves in Q1 2024: A Deep Dive into NVIDIA's Significant Reduction
GuruFocus.com via Yahoo Finance· 6 days agoModerna Inc (NASDAQ:MRNA), liquidating all 3,273,052 shares, with a -1.37% portfolio impact. Key...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 4 days ago(NASDAQ: NASDAQ:ABUS), has publicly urged the biopharmaceutical company to stop issuing shares to...